Who Paid My Doc
-Ph II (12mo treatment)
Research payments
$5,646
Through program year 2024, $5,646 in research payments was reported against -Ph II (12mo treatment), across 26 payments, paid by Boehringer Ingelheim International GmbH.
- Paid by
- Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $5,646 | 26 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Hani Salehi-Had Huntington Beach, CA Named on 1 payment
- Andres Emanuelli Anzalotta Arecibo, PR Named on 1 payment
- Jeffrey Heier Boston, MA Named on 1 payment
- Roger Goldberg Walnut Creek, CA Named on 1 payment
- Michael Borne Jackson, MS Named on 1 payment
- Hemang Pandya Plano, TX Named on 1 payment
- David Wirta Newport Beach, CA Named on 1 payment
- Sherif El Harazi Glendale, CA Named on 1 payment
- Kenneth Fan Bellaire, TX Named on 1 payment
- Joel Pearlman Sacramento, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.